Foundation Medicine and Clovis Oncology Announce Diagnostic Collaboration
06:30 EDT 6 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Foundation Medicine, Inc. and Clovis Oncology, Inc. (Nasdaq:CLVS)
announced today that they have entered into a diagnostic collaboration.
The goal of the collaboration is to develop an in-vitro diagnostic (IVD)
to identify bioma...
Other Sources for this Article
Foundation Medicine
Pure Communications, Inc.
Dan
Budwick, 973-271-6085
or
Clovis Oncology
Breanna
Burkart, 303-625-5023
Sr. Director, Investor Relations
Anna
Sussman, 303-625-5022
Sr. Director, Investor Relations
More From BioPortfolio on "Foundation Medicine and Clovis Oncology Announce Diagnostic Collaboration"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
